Cannabinoids for Inflammatory Bowel Disease: A Scoping Review
Cannabis and Cannabinoid Research · 2024
DOI: 10.1089/can.2024.0061 ↗Kurz gefasst
Scoping Review in der Zeitschrift Cannabis and Cannabinoid Research, 2024. Verfasst von Alen Brodaric und 2 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Surgery, Royal Prince Alfred Hospital, Camperdown, Australia. Hauptthemen laut MEDLINE: Cannabinoids, Inflammatory Bowel Diseases, Medical Marijuana. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Colorectal Surgery, Royal Prince Alfred Hospital, Camperdown, Australia.
- Faculty of Medicine & Health, The University of Sydney, Camperdown, Australia.
- RPA Institute of Academic Surgery, Camperdown, Australia.
ORCID-Profile: Alen Brodaric
Zitieren
APA
Brodaric, A., Polikarpova, A., & Hong, J. (2024). Cannabinoids for Inflammatory Bowel Disease: A Scoping Review. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2024.0061
Vancouver
Brodaric A, Polikarpova A, Hong J. Cannabinoids for Inflammatory Bowel Disease: A Scoping Review. Cannabis and Cannabinoid Research. 2024. doi:10.1089/can.2024.0061
BibTeX
@article{Brodaric2024,
author = {Brodaric, Alen and Polikarpova, Aleksandra and Hong, Jonathan},
title = {Cannabinoids for Inflammatory Bowel Disease: A Scoping Review},
journal = {Cannabis and Cannabinoid Research},
year = {2024},
doi = {10.1089/can.2024.0061}
}
EUVIMED